The Future of Cancer Therapy: Nanomaterials and Tumor Microenvironment (IMAGE)
Caption
The translation of nanomaterials from fundamental research to clinical applications in biomedicine faces multifaceted challenges, including concerns regarding biocompatibility and long-term toxicity, uncertainties in biotransformation and in vivo metabolic pathways, spatiotemporal heterogeneity within tumors, barriers to clinical translation, and insufficient precision in regulatory control. Future directions for nanomaterials in biomedical applications must not only explore novel and more intelligent strategies but also address these existing challenges. This paper presents several promising solutions to overcome these obstacles.
Credit
Li Chen
Usage Restrictions
Credit must be given to the creator.
License
CC BY